Viridian Therapeutics Inc (NAS:VRDN)
$ 12.34 0.74 (6.38%) Market Cap: 787.57 Mil Enterprise Value: 347.92 Mil PE Ratio: 0 PB Ratio: 2.06 GF Score: 46/100

miRagen Therapeutics Inc Extraordinary Shareholders Meeting Transcript

Dec 31, 2020 / 02:00PM GMT
Release Date Price: $16.45 (-2.08%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Special Meeting of Stockholders Conference Call. (Operator Instructions) I would now like to hand the conference over to your speaker today, Mr. Jeff Hatfield. Please go ahead.

Jeffrey S. Hatfield
Miragen Therapeutics, Inc. - Independent Chairman of the Board

Thank you. Good morning, ladies and gentlemen, and welcome to the 2020 Special Meeting of Stockholders of Miragen Therapeutics, Inc. My name is Jeff Hatfield, and I serve as Chairman of the Board of Directors of Miragen Therapeutics. I will be presiding over this meeting.

At this time, I would like to call the meeting to order. Please note that this meeting is being recorded. President at the meeting today electronically are the following directors and members of the management team: Lee Rauch, Director and Chief Executive Officer; Peter Harwin, Director; Tomas Kiselak, Director; Arlene Morris, Director; Joe Turner, Director; Jonathan Violin, President and Chief Operating Officer; Jason Leverone, Chief Financial Officer. Mr.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot